Cells lacking SYTL5 undergo a shift from mitochondrial oxygen consumption to glycolysis, which may explain the correlation between low SYTL5 expression and poor survival of ACC patients. The gene discussed is SYTL5; the disease is adrenal cortex carcinoma.